Butorphanol intranasal

Drug Profile

Butorphanol intranasal

Alternative Names: Intranasal butorphanol spray

Latest Information Update: 22 May 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ikano Therapeutics
  • Class Antimigraines; Morphinans; Opioid analgesics
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Migraine; Pain

Most Recent Events

  • 22 May 2009 Discontinued - Phase-III for Migraine in USA (Intranasal)
  • 22 May 2009 Discontinued - Phase-III for Pain in USA (Intranasal)
  • 22 Aug 2005 Intranasal Technology is now called Intranasal Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top